Price is syncing
Reported smart-money activity is still available below.
1 month
+0.6%
price return
Year to date
+5.9%
price return
Recent earnings
4/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
50 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage leans bullish
14 bullish · 30 neutral · 6 bearish
Tone of tracked coverage
Halozyme Therapeutics to report Q2 2026 results on August 6
Leans bullishJul 23GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet
Leans bullishJul 23Arkansas Sues Pfizer, J&J, Others Over Drug Discount Access
Leans bearishJul 23UCRP ETF Profile: Dividends, Returns (SWB:UCRP)
Leans bullishJul 23Q1 2026 GSK plc Earnings Call Transcript
NeutralJul 23The BioNTech Omicron BA.4/ BA.5 Booster - BioNTech SE bets on updated protection
Leans bullishJul 23Merck stock trades steadily as Keytruda revenue supports earnings
Leans bullishJul 23Etcamah (camizestrant) in combination with a CDK4/6 inhibitor approved in the EU for 1st-line advanced ER-positive breast cancer
Leans bullishJul 23FMR LLC
Q1 2026 13F
$352.9M
position
AlphaYou
